Cargando…
Therapeutics Development for Alagille Syndrome
Advancements in treatment for the rare genetic disorder known as Alagille Syndrome (ALGS) have been regrettably slow. The large variety of mutations to the JAG1 and NOTCH2 genes which lead to ALGS pose a unique challenge for developing targeted treatments. Due to the central role of the Notch signal...
Autores principales: | Sanchez, Phillip, Farkhondeh, Atena, Pavlinov, Ivan, Baumgaertel, Karsten, Rodems, Steven, Zheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419306/ https://www.ncbi.nlm.nih.gov/pubmed/34497511 http://dx.doi.org/10.3389/fphar.2021.704586 |
Ejemplares similares
-
Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1
por: Brooks, Brianna M., et al.
Publicado: (2021) -
Generation and characterization of NGLY1 patient-derived midbrain organoids
por: Abbott, Joshua, et al.
Publicado: (2023) -
Alagille Syndrome Associated with Xerophthalmia
por: Moisseiev, Elad, et al.
Publicado: (2013) -
Alagille syndrome: clinical perspectives
por: Saleh, Maha, et al.
Publicado: (2016) -
Multidisciplinary Management of Alagille Syndrome
por: Menon, Jagadeesh, et al.
Publicado: (2022)